Radiofrequency Ablation Devices Market

Global Radiofrequency Ablation Devices Market by Products (Capital Equipment, Disposable Equipment, and Reusable Equipment), Applications (Cosmetology, Cardiology, [Irrigated Tip RF Ablation Catheters and Conventional RF Ablation Catheters], Cardiac Rhythm Management, Gynecology, Surgical Oncology, [Spinal Metastases, Prostate Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Colorectal Cancer, Breast Cancer, and Others], and Pain management [Knee Pain, Neck Pain, Shoulder Pain, Lower Back Pain, Upper Back Pain, and Other Pain Syndromes), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-3074
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 174
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global radiofrequency ablation devices market is anticipated to register a high CAGR during the forecast period, between 2021 and 2028. Radiofrequency ablation devices are the approach utilized for medical operations, such as minimally invasive surgeries, which result in scarring, less pain, and rapid recovery for the patient. The devices comprise a process in which the electrical conduction system of a heart, tumor or other tissues is ablated utilizing heat produced by alternating current at a medium frequency. Because of its ease of administration, high efficacy, and safety, it has become a preferred approach. The radiofrequency current does not activate nerves and only treats a specific tissue without causing collateral damage. It is widely used in a variety of operations such as cardiology, gynecology, pain management, and others.

Radiofrequency Ablation Devices Market key takeaways

Market Trends, Drivers, Restraints, and Opportunities:

  • Growing preference for minimally invasive surgeries, increasing healthcare spending for better disease treatment, and increasing senior population are expected to drive the market.
  • Increased prevalence of chronic diseases such as arthritis and osteoporosis, as well as developing healthcare infrastructure, are driving the market.
  • Advancement of various treatment approaches is boosting the market.
  • Rising incidence of esophageal and gastric illnesses is the primary driver of the radiofrequency ablation device market.
  • High treatment costs, availability of alternative treatments, and little awareness of the procedure hamper the market.
  • Product innovations and technical advancements are creating significant growth opportunities for market players.

Scope of the report:

The report on the radiofrequency ablation devices market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Radiofrequency Ablation Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Capital Equipment, Disposable Equipment, and Reusable Equipment), Applications (Cosmetology, Cardiology, [Irrigated Tip RF Ablation Catheters and Conventional RF Ablation Catheters], Cardiac Rhythm Management, Gynecology, Surgical Oncology, [Spinal Metastases, Prostate Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Colorectal Cancer, Breast Cancer, and Others], and Pain management [Knee Pain, Neck Pain, Shoulder Pain, Lower Back Pain, Upper Back Pain, and Other Pain Syndromes),

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

AtriCure, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Halyard Health, Inc.; Stryker Corporation; C. R. Bard, Inc.; Hologic, Inc.; AngioDynamics, Inc.; Medtronic Plc.; and Smith & Nephew

 

Radiofrequency Ablation Devices Market Segment Insights:

The disposable equipment segment is projected to hold significant market share

Based on products, the radiofrequency ablation devices market can be segregated into capital equipment, disposable equipment, and reusable equipment. The disposable equipment segment is projected to hold significant market share, due to advanced technology that can create vast regions of coagulate necrosis in a controlled manner, is generally less toxic, and has a low risk of consequences. Furthermore, the connecting cords supplied with single-use probes are long enough to remain outside of the sterile region, preventing infection. It also enables a temperature-controlled lesion formation method. This increases demand for disposable products.

Radiofrequency Ablation Devices Market by products

The surgical oncology segment is anticipated to account for a substantial share

On the basis of applications, the market can be fragmented into cosmetology, cardiology, cardiac rhythm management, gynecology, surgical oncology, and pain management. The cardiology segment can be further segmented into irrigated tip RF ablation catheters and conventional RF ablation catheters. The surgical oncology segment can be further divided into spinal metastases, prostate cancer, lung cancer, liver cancer, kidney cancer, colorectal cancer, breast cancer, and others. The pain management segment can be segregated into knee pain, neck pain, shoulder pain, lower back pain, upper back pain, and other pain syndromes. The surgical oncology segment is anticipated to account for a substantial share. Surgical oncology is gaining popularity as radiofrequency ablation can be utilized to treat cancerous cells in order to enhance the survival of high-risk patients with refractory malignancies and unresectable.

North America is expected to dominate the market

In terms of regions, the radiofrequency ablation devices market can be classified as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market. The high frequency of cancer, great purchasing power, scientific innovations, and government backing for quality healthcare are all major elements leading to regional growth.

Radiofrequency Ablation Devices Market by regions

Segments

Segments Covered in the Report:

By Products

  • Capital Equipment
  • Disposable Equipment
  • Reusable Equipment
By Applications
  • Cosmetology
  • Cardiology
    • Irrigated Tip RF Ablation Catheters
    • Conventional RF Ablation Catheters
  • Cardiac Rhythm Management
  • Gynaecology
  • Surgical Oncology
    • Spinal Metastases
    • Prostate Cancer
    • Lung Cancer
    • Liver Cancer
    • Kidney Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Other Cancers
  • Pain management
    • Knee Pain
    • Neck Pain
    • Shoulder Pain
    • Lower Back Pain
    • Upper Back Pain
    • Other Pain Syndromes
By Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
By Key Players
  • AtriCure, Inc.
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation
  • C. R. Bard, Inc.
  • Hologic, Inc.
  • AngioDynamics, Inc.
  • Medtronic Plc.
  • Smith & Nephew

Competitive Landscape

Key players in the radiofrequency ablation devices market include AtriCure, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Halyard Health, Inc.; Stryker Corporation; C. R. Bard, Inc.; Hologic, Inc.; AngioDynamics, Inc.; Medtronic Plc.; and Smith & Nephew. These players have constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.

Radiofrequency Ablation Devices Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radiofrequency Ablation Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Radiofrequency Ablation Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Radiofrequency Ablation Devices Market - Supply Chain
  4.5. Global Radiofrequency Ablation Devices Market Forecast
     4.5.1. Radiofrequency Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Radiofrequency Ablation Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Radiofrequency Ablation Devices Market Absolute $ Opportunity
5. Global Radiofrequency Ablation Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Radiofrequency Ablation Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
6. North America Radiofrequency Ablation Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Radiofrequency Ablation Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
7. Latin America Radiofrequency Ablation Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Radiofrequency Ablation Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
8. Europe Radiofrequency Ablation Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Radiofrequency Ablation Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Radiofrequency Ablation Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Radiofrequency Ablation Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Radiofrequency Ablation Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Radiofrequency Ablation Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Radiofrequency Ablation Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Radiofrequency Ablation Devices Market: Market Share Analysis
  11.2. Radiofrequency Ablation Devices Distributors and Customers
  11.3. Radiofrequency Ablation Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. AtriCure, Inc.
     11.4.2. St. Jude Medical, Inc.
     11.4.3. Boston Scientific Corporation
     11.4.4. Halyard Health, Inc.
     11.4.5. Stryker Corporation
     11.4.6. C. R. Bard, Inc.
     11.4.7. Hologic, Inc.

Segments Covered in the Report:

By Products

  • Capital Equipment
  • Disposable Equipment
  • Reusable Equipment
By Applications
  • Cosmetology
  • Cardiology
    • Irrigated Tip RF Ablation Catheters
    • Conventional RF Ablation Catheters
  • Cardiac Rhythm Management
  • Gynaecology
  • Surgical Oncology
    • Spinal Metastases
    • Prostate Cancer
    • Lung Cancer
    • Liver Cancer
    • Kidney Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Other Cancers
  • Pain management
    • Knee Pain
    • Neck Pain
    • Shoulder Pain
    • Lower Back Pain
    • Upper Back Pain
    • Other Pain Syndromes
By Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
By Key Players
  • AtriCure, Inc.
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation
  • C. R. Bard, Inc.
  • Hologic, Inc.
  • AngioDynamics, Inc.
  • Medtronic Plc.
  • Smith & Nephew

Key players in the radiofrequency ablation devices market include AtriCure, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Halyard Health, Inc.; Stryker Corporation; C. R. Bard, Inc.; Hologic, Inc.; AngioDynamics, Inc.; Medtronic Plc.; and Smith & Nephew. These players have constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.

Radiofrequency Ablation Devices Market by key players

Buy Report